whatpeptidestostackLongevity and mitochondria
What the published literature pairs among longevity and mitochondrial compounds, graded by evidence. Almost everything here is studied alone.
Compounds in this area
A tetrapeptide studied for aging biology. Most evidence is animal or laboratory, with one older controlled clinical stud
GlutathioneA tripeptide antioxidant made in the body and studied in many small human trials. No approved therapeutic use appears he
MOTS-cA mitochondrial-derived peptide studied mainly for metabolism in mice. Human data are observational only, and no complet
SLU-PP-332A synthetic exercise mimetic studied in mice for metabolism, heart failure and kidney aging. No human has been given it
Graded pairings
Glutathione and SLU-PP-332
These two appear in one laboratory study, but only because glutathione was measured as a readout while cells were treated with SLU-PP-332.
Open →Reading this goal in one minute
Four compounds sit here, and one graded pairing touches them: Glutathione and SLU-PP-332. They're co-studied only because glutathione was measured as a readout in a lab study of SLU-PP-332.
No study on record has given any two of these together as a treatment.
The evidence behind each is mostly animal or lab work:
- Epithalon has one older controlled clinical study.
- Glutathione has many small human trials, and no approved therapeutic use listed here.
- MOTS-c has observational human data only.
- SLU-PP-332 has never been given to a human.
None of that shows a longevity outcome in people. Each compound profile links the studies it rests on.